Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients Gliptins and cardiometabolic risk

European Journal of Clinical Investigation

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2xvdj0J
via IFTTT